PharmChem Company Executives
| PCHM Stock | USD 3.10 0.05 1.64% |
PharmChem employs about 11 people. The company is managed by 3 executives with a total tenure of roughly 26 years, averaging almost 8.0 years of service per executive, having 3.67 employees per reported executive. Analysis of PharmChem's management performance can provide insight into the firm performance.
| Shana Veale Insider VP CFO |
| Matt Katz Insider Chief Officer |
PharmChem |
PharmChem Management Team Effectiveness
The company has return on total asset (ROA) of (0.0537) % which means that it has lost $0.0537 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2367) %, meaning that it created substantial loss on money invested by shareholders. PharmChem's management efficiency ratios could be used to measure how well PharmChem manages its routine affairs as well as how well it operates its assets and liabilities.PharmChem Workforce Comparison
PharmChem is considered to be number one stock in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 326,199. PharmChem adds roughly 11.0 in number of employees claiming only tiny portion of equities under Health Care industry.
The company has Profit Margin (PM) of (0.08) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.06) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.06. PharmChem Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. PharmChem Price Series Summation is a cross summation of PharmChem price series and its benchmark/peer.
PharmChem Notable Stakeholders
A PharmChem stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as PharmChem often face trade-offs trying to please all of them. PharmChem's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting PharmChem's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Shana Veale | VP CFO | Profile | |
| Matt Katz | Chief Officer | Profile | |
| Kerri Wagner | Chief Officer | Profile |
About PharmChem Management Performance
The success or failure of an entity such as PharmChem often depends on how effective the management is. PharmChem management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of PharmChem management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the PharmChem management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
PharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. Pharmchem is traded on OTC Exchange in the United States.
PharmChem Workforce Analysis
Traditionally, organizations such as PharmChem use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare PharmChem within its industry.PharmChem Manpower Efficiency
Return on PharmChem Manpower
| Revenue Per Employee | 2.4M | |
| Revenue Per Executive | 8.8M | |
| Net Loss Per Employee | 195.2K | |
| Net Loss Per Executive | 715.7K | |
| Working Capital Per Employee | 116.1K | |
| Working Capital Per Executive | 425.7K |
Other Information on Investing in PharmChem Pink Sheet
PharmChem financial ratios help investors to determine whether PharmChem Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PharmChem with respect to the benefits of owning PharmChem security.